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Abstract
Participants analyzed actual and simulated longitudinal data from the Framingham Heart Study for
various metabolic and cardiovascular traits. The genetic information incorporated into these
investigations ranged from selected single-nucleotide polymorphisms to genome-wide association
arrays. Genotypes were incorporated using a broad range of methodological approaches including
conditional logistic regression, linear mixed models, generalized estimating equations, linear
growth curve estimation, growth modeling, growth mixture modeling, population attributable risk
fraction based on survival functions under the proportional hazards models, and multivariate
adaptive splines for the analysis of longitudinal data. The specific scientific questions addressed
by these different approaches also varied, ranging from a more precise definition of the phenotype,
bias reduction in control selection, estimation of effect sizes and genotype associated risk, to direct
incorporation of genetic data into longitudinal modeling approaches and the exploration of
population heterogeneity with regard to longitudinal trajectories. The group reached several
overall conclusions: 1) The additional information provided by longitudinal data may be useful in
genetic analyses. 2) The precision of the phenotype definition as well as control selection in nested
designs may be improved, especially if traits demonstrate a trend over time or have strong age-of-
onset effects. 3) Analyzing genetic data stratified for high-risk subgroups defined by a unique
development over time could be useful for the detection of rare mutations in common multi-
factorial diseases. 4) Estimation of the population impact of genomic risk variants could be more
precise. The challenges and computational complexity demanded by genome-wide single-
nucleotide polymorphism data were also discussed.
Keywords
phenotype definition; trends; risk estimation; growth modeling; sampling of controls
Introduction
The identification of genetic risk factors is commonly based on case-control or cross-
sectional phenotype data in mixed-age population samples. These study designs, however,
do not allow for exploration of genetic and environmental risk factors that might influence
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the development of traits over time. If the genetic risk factors are sensitive to time effects,
the assignment of case and control status in genetic association studies may be biased.
Longitudinal data analysis in genetic studies is a unique, although rarely implemented,
strategy that provides several advantages and challenges. The longitudinal design provides
additional information regarding time of onset and therefore may allow for a more precise
definition of case and control status in association analysis. The longitudinal information is
particularly valuable for traits with variable age of onset and for traits that are heterogeneous
with regard to development over time. Longitudinal studies also allow for the prospective
measurement of time-varying factors that are not typically included in genetic case control
association studies focused solely on genetic effects, even though interactions with time-
varying environments may be important. This implies that time-variant covariates can be
measured with improved precision in longitudinal data analyses. Finally, the genetic trait of
critical interest may not be the occurrence of an event, but rather the trajectory of
performance or decline over time. Longitudinal designs are uniquely able to capture this
type of genetic trait via trajectory classes or quantitative slopes.
Besides design issues that address phenotype definition and population heterogeneity,
longitudinal analysis also provides several advantages for the statistical analysis of genetic
data. Instead of binary or cross-sectional quantitative traits, intercepts or slopes of repeated
measures can be used as quantitative phenotypes, which may capture certain characteristics
of population subgroups with unique genetic or environmental risk factors. The analysis
could capitalize on non-linear shapes of the growth curves, knot-points, or other features of
trajectories that may capture variability or stability over time.
In the Genetic Analysis Workshop 16 (GAW16), participants in Group 14 explored the
advantages and challenges of a design that integrated either actual or simulated longitudinal
phenotype data of the Framingham Heart Study (FHS) with genome-wide single-nucleotide
polymorphism (SNP) data. The participating groups took a variety of approaches
capitalizing on the additional information provided by this longitudinal study design. The
approaches included use of incidence-density sampling rather than cross-sectional case-
control selection, linear mixed modeling [McLean et al., 1991], generalized estimating
equations [Zeger and Liang, 1986], multivariate linear growth curve modeling [Duncan et
al., 1999], growth mixture modeling (GMM) [Muthén, 2004; Muthén and Asparouhov,
2008], population attributable risk fraction (PAF) based on survival functions under the
proportional hazards model, and multivariate adaptive splines for the analysis of
longitudinal data (MASAL) [Zhang, 1997; Zhang, 2004]. These contributions will be
described in the rest of the paper.
Methods
Data
The Framingham Heart Study (FHS) is the oldest prospective longitudinal cohort study of
cardiovascular risk factors in the U.S. [Cupples et al., 2007]. The original FHS cohort
included presumably unrelated healthy individuals from Framingham, MA. About 5,209
subjects (Original Cohort) were recruited between 1948 and 1953 and were followed by
biannual exams for potential cardiovascular risk factors (Cohort 1). The FHS was extended
(Offspring Cohort) to ascertain children and spouses of the Original Cohort, enrolling an
additional 5,124 individuals between 1971 and 1975 (Cohort 2). Finally, 4,095 children of
the Offspring Cohort (the grandchildren of the original participants, Generation 3) extended
the study over three generations (Cohort 3). Participants were examined in regular intervals;
however, because the study spanned three generations, the age at each exam was not
uniform. For GAW16, longitudinal data were available only for Cohort 1 and Cohort 2. In
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contrast to other cohort studies, the participants of the FHS in the combined set of cohort
collections are related to one another. Indeed, some families even consist of several hundred
individuals. Each investigative team that participated in Group 14 selected different subsets
of the data to address their specific hypothesis of interest, although all topics were related to
longitudinal data analysis. To highlight their contributions, Group 14 participants' names are
given in bold throughout.
In this paper, we will review how the Group 14 investigators applied general longitudinal
data analyses: in all individuals in Cohorts 1 and 2 [Luan et al., 2009; Zhu et al., 2009], male
individuals from Cohort 1 and Cohort 2 [Kerner and Muthén, 2009], incident cases and
controls [Fradin and Fallin, 2009], unrelated individuals from Cohort 2 [Roslin et al., 2009;
Yan et al., 2009], and select persons from Cohort 2 and Cohort 3 [Park et al., 2009] (Table
I). Lastly, one group used simulated data with known results in order to compare the power
of three different methodological approaches [Chang et al., 2009].
Modeling family relationships
A key issue in the analysis of FHS data is the modeling of the non-independence amongst
relative pairs. Four of the eight Group 14 contributions directly modeled the family structure
of the data [Kerner and Muthén, 2009; Luan et al., 2009; Park et al., 2009; Zhu et al., 2009].
Zhu et al. [2009] split the families into sibships to reduce computational complexity. Three
groups selected only unrelated individuals [Fradin and Fallin, 2009; Roslin et al., 2009; Yan
et al., 2009].
Genotypes and phenotypes
Integrating longitudinal data analysis with genome-wide SNP data caused computational
complexities and challenges that were addressed by the different groups in unique ways
(Table I). Several groups selected only SNPs or chromosomes with prior evidence of
association to the trait of interest to demonstrate their approach to longitudinal data [Chang
et al., 2009;Fradin and Fallin, 2009;Kerner and Muthén, 2009;Luan et al., 2009;Yan et al.,
2009]. Three groups used genome-wide SNP data [Park et al., 2009;Roslin et al., 2009;Zhu
et al., 2009]. The traits included in the analysis covered a wide range of metabolic and
cardiovascular traits measured on FHS participants including systolic blood pressure (SBP),
type 2 diabetes mellitus, coronary artery calcification, body mass index (BMI), weight,
metabolic syndrome (MBS), high-density lipoprotein levels (HDL), low-density lipoprotein
levels (LDL), fasting triglyceride levels (TG), and coronary artery disease (CHD) (Table I).
The data were integrated either in a one-step approach, in which genotype and phenotype
data were modeled simultaneously, or in a two-step approach that first modeled the
phenotype and then integrated the genotype information in an independent analysis (Table
I). All groups incorporated covariates into their analyses.
Software
Several computer programs were used for the analysis including SAS [Chang et al., 2009;
Fradin and Fallin, 2009; Luan et al., 2009; Park et al., 2009], Mplus [Chang et al., 2009;
Kerner and Muthén, 2009; Roslin et al., 2009], PLINK 9 [Roslin et al., 2009],
GOLDENHELIX [Kerner and Muthén, 2009], Stata [Luan et al., 2009], and MASAL [Zhu
et al., 2009] (Table I).
Overall Analytical Strategies and Results
The specific scientific focus of each group varied, with two overarching themes: more
precise definition of the genetic phenotype in a longitudinal context and application of
various statistical approaches for assessing the relationship between genes and longitudinal
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phenotypes. The particular topics included assessment of changes in cross-sectional genetic
effects over time, bias reduction in control selection using incidence density sampling, direct
incorporation of genetic data in longitudinal modeling approaches, and the exploration of
population heterogeneity with regard to longitudinal trajectories.
Because every group used a different analytical approach and a unique design to answer a
very specific scientific question, a comparison of the methods and the results across projects
was not feasible. We therefore will describe each study separately highlighting the
significant results.
Comparison of cross-sectional trends over time
Park et al. [2009] focused on the comparison of genetic association results for the synthetic
trait MBS at multiple visits over time via cross-sectional association analyses. The
investigators found that the significance of the SNP association increased over time. They
were able to replicate some of the significant associations previously reported by FHS and
identified new loci as well (Table II). They emphasized that attention to timing of case-
control analysis and to consistency in trend of effects over time are important advantages of
longitudinal data.
Nested studies from longitudinal data collection
Fradin and Fallin [2009] compared two commonly employed methods of selecting age-
matched controls for nested case-control studies, case exclusion sampling (CE), in which
both prevalent and incident cases are included but only those free of disease at censoring are
used as controls, and incidence density sampling (ID), in which only incident cases are
included and controls are selected from all participants remaining at risk for the disease at
the time a case occurs. The latter allows for those who develop disease at a later time to act
as controls for cases occurring earlier in the study, which has been shown to be less biased
than the case-exclusion approach in other areas of epidemiology. They used both the FHS
data as well as simulated data and demonstrated that ID sampling was indeed associated
with less bias in odds-ratio estimates than CE, although CE appears to be more powerful due
to the upward bias of point estimates. They concluded that the ID sampling was an
appropriate option for nested case-control genome-wide association studies and that this
design could be a very efficient approach to obtain unbiased estimates of relative risk
associated with genetic variants, especially when age is a strong risk factor for a disease
phenotype. However, the small number of incident cases in the study limited this approach.
Time-dependent PAF
Yan et al. [2009] focused on the population effect of candidate polymorphisms for CHD in
the FHS Cohort 2 and the change of the population effect over time. They estimated the
time-dependent PAF for each SNP using the Cox proportional hazards model and then
estimated the PAF for all significant SNPs combined. Because the current PAF estimation
does not account for age-of-onset data, this group was able to extend the current PAF
analysis and to create a more comprehensive estimate of population impact over the life-
course of disease by incorporating the age of onset of CHD into the formulation of the
hazard function. They also explored the association with the risk score, which was
constructed by summing the number of risk alleles across three CHD susceptibility SNPs
(rs1333049 close to the CDKN2A/2B gene, rs618675 in the GJA4 gene, and rs1376251 in
the TAS2R50 gene) out of 23 that had been significantly associated with the incident CHD
(Table II). The risk score was significantly associated with incident CHD risk (p=0.0004).
They concluded that this novel tool for population impact may improve the understanding of
genetic risk factors at the population level.
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Use of trajectories as genetic phenotype
Splines—Zhu et al. [2009] explored trajectories as genetic phenotype in a genome-wide
modeling approach in independent individuals using MASAL [Zhang, 1997; Zhang, 2004].
This approach uses a nonparametric regression (forward/backward regression) to estimate
regression coefficients that estimate gene, environment, time, and interaction effects. This
method can accommodate time-varying covariates, and test for interactions between genes
and environmental factors as well as between time and covariates. The group identified 13
significant SNP associations for Cohort 2 and 6 SNP associations for the Cohort 1 (Table
II), as well as significant SNP-SNP and SNP-environment interactions. However, the
significant SNPs in Cohort 1 and 2 samples did not overlap.
Quantitative traits (intercepts and slopes)—Luan et al. [2009] took a candidate gene
approach to the longitudinal data, estimating the SNP effects on BMI and weight over time.
The group fitted a mixed effects model and compared the intercepts and slopes of the growth
curves in groups stratified by the genotypes of known risk alleles. This analysis confirmed
the effect of the risk alleles of the SNPs in cross-sectional data (intercept results) and
demonstrated a significant effect of the SNPs on the slopes of the developmental trajectories
as well.
Roslin et al. [2009] attempted to incorporate the information provided by the longitudinal
design into genome-wide SNP association analyses. For this approach they first estimated
intercepts and slopes for four different traits in separate multivariate growth models of: 1)
SBP, 2) HDL, 3) LDL, and 4) TG. Due to the computational resources required to process
data for millions of SNP genotypes, the group followed a two-step design, by first
estimating the individual intercepts and slopes of the multivariate growth curves and then
regressing these (scalar) features on the SNP genotypes. Slopes and intercepts were regarded
as separate traits in eight separate linear regression genetic analyses. The group found a
significant association of SNP rs599839 on chromosome 1p13 with the intercept of the trait
LDL but not with the slope. Marker rs765547 was associated with both the HDL slope and
the TG slope (Table II). This marker is located about 41 kb downstream from the gene
lipoprotein lipase (LPL) on chromosome 8p21.
Trajectory classes—Chang et al. [2009] used the genotype information of previously
associated SNPs to predict latent class growth curves and latent class membership (the
probability that a genotype affects the probability of the trajectory component membership).
In order to accomplish this goal, they compared three different approaches, 1) the likelihood
ratio test statistic (LRTS), 2) a direct test of genetic model coefficients, and 3) the chi-square
test classifying subjects based on the trajectory model's posterior Bayesian probability. The
group found that the LRTS was not usable due to non-normal distribution of the outcome
and non-independence of the individuals in the study. The other two tests were satisfactory.
Power was still substantial when markers near the gene rather than the gene itself were used.
For markers near the actual gene, there was somewhat greater power for the direct test of the
coefficients and lesser power for the posterior Bayesian probability chi-square test. Time-
varying covariates did not increase overall power due to instability.
Heterogeneity addressed by growth mixture modeling
Kerner and Muthén [2009] explored heterogeneity in the data with respect to SBP
trajectories over time using GMM in Mplus. In order to incorporate genotype information
into the model, they took a two-step approach. First, they estimated the class membership
probability based on SBP development over time and then they used the latent class
membership probability as phenotype in a quantitative trait analysis. This approach allowed
for a more homogeneous classification of individuals with regard to the phenotype and it
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facilitated the identification of an association with a rare coding variant in a subgroup of
individuals. They concluded that GMM could be a useful approach to phenotype
heterogeneity in mixed age samples for traits with strong age effects.
Discussion
GAW16 participants revisited the FHS data for their analysis and participants of Group 14
in particular focused on the longitudinal aspect of the data. In previous workshops, the
longitudinal focus had been on the use of intercepts and slopes as phenotypes in genetic
analysis [Gauderman et al., 2003]. This year's contributions extended these approaches to
include a variety of research questions for which longitudinal data could be useful. This
exercise revealed several challenges, often related to handling large amounts of phenotype
and genotype data and to limited numbers of events for many phenotypes. As the amount of
genetic data in longitudinal studies available to researchers continues to increase, the
challenges in attempting to incorporate longitudinal data analysis with genetic analysis will
become increasingly critical.
Advantages of longitudinal data analysis include the possibility of finding more
homogenous groups of individuals that share a common trajectory. Under this scenario,
mean effects appear to be easier to detect than slopes or other trajectory features, and the
longitudinal approach, borrowing information on individuals across time, may improve
precision over analyses of a single visit. Longitudinal data analysis is advantageous for
detecting genes that affect trajectories, rather than simple differences in phenotype values
because the trajectory information provides a more specific trait for genetic analysis aimed
at detecting such genes. Longitudinal data is also useful for identifying genetic causes that
have strong age of onset effects because the use of age at disease onset will be a more
specific phenotype for genetic analysis in this context than cross-sectional information about
disease status. Certain traits have strong heterogeneity with regard to the underlying
pathophysiological conditions dependent on the age of onset. SBP is a classic example. High
blood pressure early in life often has its cause in renal pathology, whereas elevated blood
pressure later in life is more commonly caused by cardiovascular changes. Attention to
timing and trajectory of phenotype can help to clarify these insights.
Even though the longitudinal cohort study design has clear advantages for some questions,
there are limitations. For example, analyses that focused on incident cases in cohort studies
were underpowered due to a small number of events. Further, the results presented within
this analysis group show the current lack of clear analytic strategies to deal with the complex
longitudinal data structures. Not a single group was able to capitalize on all the data
available: especially the integration of the large number of genotypes in the context of both
repeated measures and family relationship. Future work should focus on the development of
analytical methods and computer software that can handle these longitudinal data in the
context of other complexities that are often found in cohort studies. The lack of software
solutions that can handle millions of data points in a practical amount of time led many
groups to a two-step design in which the phenotype data were analyzed separately from the
genotype data. For example, the Mplus analyses performed by Kerner and Muthen [2009],
which allow inclusion of up to 50 auxiliary variables, would have taken approximately
20,000 days (∼ 55 years) for one-step analysis of 500,000 markers on a 64-bit 8-core
machine. The two-step solution is far from ideal, however, and potentially biased. Other
groups limited the analysis to only a small number of selected SNPs, assumed to be genetic
risk factors for a given trait or phenotype. This design is also not ideal because it excludes
the majority of SNPs that could potentially be important as risk factors in a particular study
sample.
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The GAW 16 data sets offered a unique opportunity to explore many approaches to
longitudinal data analysis. From the diversity of strategies applied and evaluated in GAW16,
especially those applied and evaluated as part of Group 14, it became apparent that there are
many important methodological approaches available for implementing longitudinal data
analysis. Unfortunately, the wide array of analyses performed in Group 14 did not allow for
direct comparison of the different approaches. Future studies could suggest a more targeted
effort in order to further evaluate the approaches and their usefulness under certain design
conditions. Taken together, Group 14 contributions demonstrate the opportunities provided
by longitudinal data and highlight the need for a combination of strategies to implement
longitudinal data analysis.
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